These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15884521)

  • 1. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Nagpal M
    Indian J Ophthalmol; 2001 Jun; 49(2):141; author reply 141-2. PubMed ID: 15884521
    [No Abstract]   [Full Text] [Related]  

  • 2. Transpupillary thermotherapy for choroidal neovascular membrane in age related macular degeneration.
    Roy P
    Indian J Ophthalmol; 2004 Sep; 52(3):262; author reply 262. PubMed ID: 15510478
    [No Abstract]   [Full Text] [Related]  

  • 3. Transpupillary thermo therapy for the treatment of choroidal neovascularisation secondary to age related macular degeneration in Indian eyes.
    Verma L; Sinha A; Nainiwal S; Tewari HK
    Indian J Ophthalmol; 2004 Mar; 52(1):86-7; author reply 87. PubMed ID: 15132395
    [No Abstract]   [Full Text] [Related]  

  • 4. New treatments for neovascular age-related macular degeneration: when should we use them?
    Kvanta A
    Acta Ophthalmol Scand; 2007 Feb; 85(1):5. PubMed ID: 17244203
    [No Abstract]   [Full Text] [Related]  

  • 5. The 1-year follow-up results of 35 eyes of 35 patients with occult choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) who were treated by transpupillary thermotherapy (TTT).
    Arashvand K; Pearson R
    Retina; 2008 Jan; 28(1):186; author reply 186-7. PubMed ID: 18185165
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of neovascular age-related macular degeneration: past, present and future directions.
    Smith BT; Joseph DP; Grand MG
    Curr Opin Ophthalmol; 2007 May; 18(3):240-4. PubMed ID: 17435433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which treatment is best for which AMD patient?
    Kroll P; Meyer CH
    Br J Ophthalmol; 2006 Feb; 90(2):128-30. PubMed ID: 16424516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neovascular AMD: out of the forest and into the trees.
    Yannuzzi LA
    Retina; 2007; 27(6):655-61. PubMed ID: 17621173
    [No Abstract]   [Full Text] [Related]  

  • 9. Macular microcirculation blood flow in patients with age related macular degeneration treated with photodynamic therapy and transpupillary thermotherapy.
    Kubicka-Trzaska A
    Klin Oczna; 2007; 109(4-6):138-41. PubMed ID: 17725271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence.
    Virgili G; Do DV; Bressler NM; Menchini U
    Acta Ophthalmol Scand; 2007 Feb; 85(1):6-20. PubMed ID: 17244204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low power vs standard power transpupillary thermotherapy in patients with age-related macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy.
    Hogan AC; Kilmartin DJ
    Eye (Lond); 2006 Jun; 20(6):649-54. PubMed ID: 16082398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale for drug combinations in age-related macular degeneration.
    Adamis AP
    Retina; 2009 Jun; 29(6 Suppl):S42-4. PubMed ID: 19553800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies for neovascular age-related macular degeneration: state of the art.
    Donati G
    Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F; Lafuma A; Berdeaux G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transpupillary thermotherapy in the treatment of choroidal neovascularization in age-related macular degeneration--one year's results].
    Studnicka J; Rencová E; Korda V; Hejcmanová D; Dusová J; Kvasnicka J
    Cesk Slov Oftalmol; 2006 May; 62(3):190-9. PubMed ID: 16758759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wet age-related macular degeneration.
    Kulkarni AD; Kuppermann BD
    Adv Drug Deliv Rev; 2005 Dec; 57(14):1994-2009. PubMed ID: 16309781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal function following transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration: a short-term study by focal electroretinography.
    Pirozzi E; Manganelli C; Piccardi M; Minnella A; Fadda A; Ziccardi L; Coccimiglio F; Falsini B
    Acta Ophthalmol Scand; 2006 Feb; 84(1):27-35. PubMed ID: 16445436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transpupillary thermotherapy in exudative age-related macular degeneration].
    Kubicka-Trzaska A; Starzycka M; Ortyl E; Górniak-Bednarz A; Karska-Basta I
    Klin Oczna; 2007; 109(4-6):142-5. PubMed ID: 17725272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.
    Korobelnik JF; Moore N; Blin P; Dharmani C; Berdeaux G
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4270-6. PubMed ID: 17003415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.